Blood disorders can affect any of the three main components of blood:
Red blood cells, which carry oxygen to the body's tissues
White blood cells, which fight infections
Platelets, which help blood to clot
Blood disorders can also affect the liquid portion of blood, called plasma.
Treatments and prognosis for blood diseases vary, depending on the blood condition and its severity.
Standard treatment options for myelodysplastic syndromes include:
Supportive care with one or more of the following:
Treatments to slow progression to acute myeloid leukemia (AML):
Azacitidine and decitabine.
Chemotherapy used in acute myeloid leukemia.
Chemotherapy with stem cell transplant.
Treatment of Therapy-Related Myeloid Neoplasms
Patients who were treated in the past with chemotherapy or radiation therapy may develop myeloid neoplasms related to that therapy. Treatment options are the same as for other myelodysplastic syndromes.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with adult myelodysplastic syndromes. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.